CGON vs. CANC
CGON (CG Oncology, Inc) is a stock, while CANC (Tema Oncology ETF) is Health & Biotech Equities fund actively managed by Tema. Over the past year, CGON returned 103.14% vs 47.37% for CANC. A 0.52 correlation means they provide meaningful diversification when combined.
Performance
CGON vs. CANC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CGON achieves a 31.07% return, which is significantly higher than CANC's 4.82% return.
CGON
- 1D
- -2.00%
- 1M
- -19.62%
- YTD
- 31.07%
- 6M
- 27.72%
- 1Y
- 103.14%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CANC
- 1D
- 0.08%
- 1M
- -3.73%
- YTD
- 4.82%
- 6M
- 3.86%
- 1Y
- 47.37%
- 3Y*
- 107.76%
- 5Y*
- —
- 10Y*
- —
CGON vs. CANC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CGON CG Oncology, Inc | 31.07% | 44.77% | -22.84% |
CANC Tema Oncology ETF | 4.82% | 42.92% | -4.51% |
Correlation
The correlation between CGON and CANC is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.52 |
Correlation (All Time) Calculated using the full available price history since Jan 26, 2024 | 0.52 |
The correlation between CGON and CANC has been stable across timeframes, ranging from 0.52 to 0.52 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CGON vs. CANC — Risk / Return Rank
CGON
CANC
CGON vs. CANC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CG Oncology, Inc (CGON) and Tema Oncology ETF (CANC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CGON | CANC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.23 | ||
| Sortino ratioReturn per unit of downside risk | -0.14 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.34 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.92 | 5.49 | -1.57 |
| Martin ratioReturn relative to average drawdown | 13.56 | 14.62 | -1.06 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CGON | CANC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.83 | 2.06 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.28 | -0.04 | +0.31 |
Drawdowns
CGON vs. CANC - Drawdown Comparison
The maximum CGON drawdown since its inception was -67.47%, smaller than the maximum CANC drawdown of -97.53%. Use the drawdown chart below to compare losses from any high point for CGON and CANC.
Loading charts...
Drawdown Indicators
| CGON | CANC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.47% | -97.53% | +30.06% |
Max Drawdown (1Y)Largest decline over 1 year | -26.46% | -8.67% | -17.79% |
Max Drawdown (3Y)Largest decline over 3 years | — | -30.27% | — |
Current DrawdownCurrent decline from peak | -26.46% | -56.55% | +30.09% |
Average DrawdownAverage peak-to-trough decline | -25.94% | -73.19% | +47.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.63% | 3.25% | +4.38% |
Volatility
CGON vs. CANC - Volatility Comparison
CG Oncology, Inc (CGON) has a higher volatility of 14.38% compared to Tema Oncology ETF (CANC) at 6.26%. This indicates that CGON's price experiences larger fluctuations and is considered to be riskier than CANC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CGON | CANC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.38% | 6.26% | +8.12% |
Volatility (6M)Calculated over the trailing 6-month period | 41.68% | 16.69% | +24.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.74% | 23.11% | +33.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.20% | 280.27% | -216.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 64.20% | 280.27% | -216.07% |
Dividends
CGON vs. CANC - Dividend Comparison
CGON has not paid dividends to shareholders, while CANC's dividend yield for the trailing twelve months is around 0.05%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
CANC Tema Oncology ETF | 0.05% | 0.06% | 3.00% | 0.56% |
CGON CG Oncology, Inc | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CGON and CANC have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CGON has higher volatility (14.38%) compared to CANC (6.26%). In terms of maximum drawdown, CGON dropped -67.47% vs CANC's -97.53%.
CANC currently has the higher Sharpe Ratio (2.06 vs 1.83), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CGON and CANC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer